NCL’s first fund is based at Discovery Park and invests primarily in a diverse range of biotech and environmental technologies:

NCL also manage some existing equity investments of one of our main local authority investors:

Capital markets standalone activity:

We are shortly due to announce our new fund focusing on Immunotherapy and medical technology.